BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Institute for Bioengineering of Catalonia - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://ibecbarcelona.eu/ca/
X-WR-CALDESC:Esdeveniments per Institute for Bioengineering of Catalonia
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Madrid
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20210328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20211031T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20220327T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20221030T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20230326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20231029T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Madrid:20220701T090000
DTEND;TZID=Europe/Madrid:20220701T174500
DTSTAMP:20260425T173456
CREATED:20220623T112616Z
LAST-MODIFIED:20220623T112616Z
UID:97446-1656666000-1656697500@ibecbarcelona.eu
SUMMARY:THERACAT Conference
DESCRIPTION:Bio-orthogonal catalysis for cancer therapy (THERACAT)\n\n\nTHERACAT is a Marie Skłodowska-Curie European Training Network (MSCA-ITN-ETN) aiming to train a new generation of researchers on the innovative topic of bio-orthogonal catalysis for cancer therapy \nThe development of novel cancer therapies is a major challenge for academic research and pharmaceutical industries. Although the recent progress in traditional treatments such as surgery and chemotherapy improved the clinical outcome of cancer patients\, there is a strong need for new and effective approaches as well as for a new generation of young scientists trained to tackle these challenges from a multidisciplinary perspective. THERACAT establishes an international training programme focused on the development of catalysis-based approaches towards the cure of cancer. In this strategy nano- and micro-particles bearing a catalytic unit are delivered to the tumour site and subsequently non-active prodrugs are administered to the patient. The prodrugs are non-toxic and therefore generate limited side effects. Only at the tumour site the catalytic particles convert the prodrugs into active anticancer compounds that generate a local and strong effect\, as single catalytic species can uncage a large number of drugs. This approach presents several advantages on the classical drug delivery paradigm including limited side effects and prolonged efficacy. \nThe final aim of the THERACAT network is to consolidate Europe as the world leader in novel catalysis-based approach for cancer therapy. \n 
URL:https://ibecbarcelona.eu/ca/event/theracat-conference/
LOCATION:Sala Dolors Aleu\, Parc Científic de Barcelona\, Barcelona\, Spain
CATEGORIES:External symposium / conference / congress
ORGANIZER;CN="IBEC":MAILTO:www.ibecbarcelona.eu
END:VEVENT
END:VCALENDAR